Failure to monoclonal antibodies against CGRP or its receptor does not preclude lack of efficacy to other drugs from the same therapeutic class

  1. Porta-Etessam, J.
  2. González-García, N.
  3. Guerrero, Á.L.
  4. García-Azorín, D.
Aldizkaria:
Neurologia

ISSN: 1578-1968,  0213-4853

Argitalpen urtea: 2021

Alea: 36

Zenbakia: 8

Orrialdeak: 638-640

Mota: Gutuna

DOI: 10.1016/J.NRL.2020.10.009 GOOGLE SCHOLAR lock_openSarbide irekia editor